NewsCBS News PoliticsMay 7, 2026United States
Trump Administration Drug Price Initiatives: What Has Changed?
The Trump administration has launched several initiatives, including the 'TrumpRx' discount portal, aimed at lowering prescription drug costs. While some patients may see savings on specific medications, data shows that overall list prices for many brand-name drugs continue to rise, and the impact of these new programs remains limited compared to ongoing Medicare price negotiations.
Read the full story at CBS News PoliticsWhy It Matters
Residents may see price changes for specific brand-name drugs through the TrumpRx portal, while Medicare enrollees continue to benefit from federally negotiated price caps on high-cost medications.
Key Facts
- Medicare drug price negotiations for the first 10 drugs went into effect January 1, 2026, with price reductions over 50%.
- Medicare Part D out-of-pocket spending is capped at $2,000 for 2025 and beyond.
- Negotiated Medicare prices for an additional 15 high-priced drugs take effect in 2027.
- The TrumpRx portal launched February 6, 2026, offering discounts primarily on Pfizer products for cash-paying patients.
- 46brooklyn reported that nearly 1,000 brand-name drugs increased in price in January 2026.
- Pfizer raised list prices on 71 drugs by an average of 5% in early 2026.
- The One Big Beautiful Bill Act exempts drugs for rare diseases from federal price negotiations.
- TrumpRx offers discounts on specific fertility drugs, such as Gonal-F, for cash-paying patients.
- Most TrumpRx discounts are only available to patients without insurance who pay cash.
Who's Mentioned
organization46brooklyn“Data project tracking drug prices”organizationPfizer“Pharmaceutical company”personAlbert Bourla“CEO of Pfizer”personSean Tu“Patent law expert at the University of Alabama”personMark Cuban“Billionaire investor and founder of Cost Plus Drugs”personKush Desai“White House spokesperson”personAaron Kesselheim“Professor of medicine at Harvard Medical School”personDonald Trump“President of the United States”personAntonio Ciaccia“Co-founder of 46brooklyn”organizationMark Cuban Cost Plus Drug Co.“Generic drug retailer”